Cancer-Related Therapies at the End of Life in Hospitalized Cancer Patients from Four Swiss Cantons: SAKK 89/09
Klazien Matter‐Walstra(University of Basel), Matthias Schwenkglenks(University of Basel)
Cited by 13
Related Papers
How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts
|The European Journal of Health Economics|2018|59
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study
|European Journal of Clinical Pharmacology|2014|28